Palvella Therapeutics (PVLA) Net Cash Flow: 2013-2024
Historic Net Cash Flow for Palvella Therapeutics (PVLA) over the last 11 years, with Dec 2024 value amounting to $69.4 million.
- Palvella Therapeutics' Net Cash Flow rose 661.73% to $69.4 million in Q4 2024 from the same period last year, while for Dec 2024 it was $87.6 million, marking a year-over-year increase of 2555.56%. This contributed to the annual value of $76.3 million for FY2024, which is 2212.49% up from last year.
- As of Q4 2024, Palvella Therapeutics' Net Cash Flow stood at $69.4 million, which was up 37,031.91% from -$188,000 recorded in Q3 2024.
- Over the past 5 years, Palvella Therapeutics' Net Cash Flow peaked at $69.4 million during Q4 2024, and registered a low of -$33.0 million during Q1 2022.
- In the last 3 years, Palvella Therapeutics' Net Cash Flow had a median value of $359,500 in 2023 and averaged $1.4 million.
- In the last 5 years, Palvella Therapeutics' Net Cash Flow soared by 1,488.58% in 2021 and then crashed by 1,235.75% in 2022.
- Palvella Therapeutics' Net Cash Flow (Quarterly) stood at $1.5 million in 2020, then plummeted by 523.13% to -$6.4 million in 2021, then tumbled by 83.76% to -$11.7 million in 2022, then skyrocketed by 177.69% to $9.1 million in 2023, then skyrocketed by 661.73% to $69.4 million in 2024.
- Its Net Cash Flow was $69.4 million in Q4 2024, compared to -$188,000 in Q3 2024 and $10.5 million in Q2 2024.